Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia

Stopped early · Phase 2

Conditions studied: Leukemia

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of methotrexate with or without cyclophosphamide in treating patients who have lymphocytic leukemia with neutropenia or anemia.

Key facts

Study ID
NCT00003910
Run by
Eastern Cooperative Oncology Group
People needed
59
Starts
1999-09-15
Expected to finish
2012-03-01
Last updated by the study team
2023-07-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.